CVS pulling popular cold meds from shelves after report deems them to be useless
Surprising finding links sleep, brain insulation and neurodegeneration
People with intellectual disability are often diagnosed with cancer when it is already well advanced
Study confirms efficacy of ezetimibe combination therapy for LDL-C reduction in high risk patients
Dietitian reveals the ONE leafy green vegetable that's the healthiest
Study reveals no neuroinflammation in long COVID patients with neuropsychiatric symptoms
Consistent lack of sleep related to future depressive symptoms, genetic study finds
Type 2 diabetes: New GLP-1 agonist may lead to long-lasting treatment
Gremlin 1 cells discovery offers hope to treat and reverse osteoarthritis
Using virtual reality to create therapeutic experiences: From treating phobias to rehabilitating abusers
Eight steps that ‘slow your body’s ageing process by six years
Early life stress circumstances alters more genes in the brain than head injuries
Is ChatGPT Smarter Than a PCP?
WHO says AI can transform health care if understood properly
Achieve stress-free pipetting with INTEGRA Biosciences’ new eBook
What happens when we pass out? Researchers identify new brain and heart connections
Genetic risk scores not useful in predicting disease, study argues
Psychological Safety in Cardiology Training
Researchers develop AI-based tool for estimating cancer patient's chances for survival
US surgeons perform world’s first whole eye transplant
High-intensity focused ultrasound procedure treats localized prostate cancer while preserving urinary, sexual function
A vicious cycle: Research examines depression as both cause and consequence of stress
Scientists find a stem-cell derived mechanism that could lead to regenerative therapies for heart damage
Psychologists want to ban TICKLING – here's the bizarre reason why
New prediction model estimates risk of opioid relapse early in treatment
Higher Weight Loss on Tirzepatide Links to Seven Factors
Doctors warning as dementia linked to common health issue 6 million Brits have
Metixene identified as a promising candidate in the treatment of metastatic brain cancer
